https://www.selleckchem.com/pr....oducts/Simvastatin(Z
as the primary inotrope following pediatric cardiac surgery. Atorvastatin is considered as lipid reductive drugs with anti-inflammatory and pleotherapic effects in coronary artery bypass graph (CABG). This study is conducted to evaluate the effects of atorvastatin in CABG. Patients with a coronary bypass graph procedure in Nemazee hospital in Shiraz were divided into two 50-groups receiving high-dose (80 mg) and low-dose (20 mg) atorvastatin. Troponin I, creatinine kinase-MB (CK-M, atrial fibrillation (AF) after CABG, durat